Stage III Non-Small Cell Lung Cancer AJCC v7 Terminated Phase 1 / 2 Trials for Cyclophosphamide (DB00531)

Also known as: Stage III Lung Non-Small Cell Cancer AJCC v7

IndicationStatusPhase
DBCOND0090379 (Stage III Non-Small Cell Lung Cancer AJCC v7)Terminated1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02408016Genetically Modified T Cells in Treating Patients With Stage III-IV Non-small Cell Lung Cancer or MesotheliomaTreatment